Minondas, Stieven Jhon R.
HRN: 10-05-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2023
MUPIROCIN 2%, 15G (TUBE)
03/09/2023
03/15/2023
TOPICAL
2%
Q8hrs
Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes